Whitepapers | November 21, 2011 | Samir Kapadia, Heart and Vascular Institute Cleveland

syngo DynaCT Cardiac Paravalvular Mitral Valve Leakage

Figure 3: syngo DynaCT Cardiac with syngo iGuide Toolbox markers indicating the positions of the paravalvular leaks from TEE.

Figure 4: syngo DynaCT Cardiac with syngo iGuide Toolbox markers indicating the plane of the aortic valve.

Figure 5: syngo DynaCT Cardiac with syngo iGuide Toolbox markers indicating the desired region of the transseptal puncture.


Patient History
72-year-old, male patient with previously placed bioprosthetic mitral valve.
 

Diagnosis
Mitral regurgitation (grade 3+) due to periprosthetic leak (Video 1). To view the videos click here.
 

Treatment
Closure of the paravalvular leak with an 8 mm VSD closure device under TEE (transesophageal echo) and fluoroscopic guidance. syngo iGuide Toolbox graphics were overlaid as additional guidance.

Comments
The case demonstrated that the overlay of 3-D information on the live fluoroscopic images provided additional helpful information.?? More detailed information can be found in the following publication:? Krishnaswamy A, Tuzcu EM, Kapadia S. "Three-dimensional computed tomography in the cardiac catheterization laboratory." Catheter Cardiovasc Interv. 2010

Detailed Workflow Description
Pre-procedural cardiac CT data was retrieved from the PACS. (Video 2) The following structures were marked with syngo iGuide Toolbox graphics:
    •    Mitral valve plane
    •    Positions of the paravalvular leaks (based on the information of the diagnostic TEE Picture 3 )
    •    Aortic valve plane (Picture 4)
    •    Area for transseptal puncture (Picture 5)
?

The patient was positioned on the table with arms up to match the patient’s position during the pre-procedural cardiac CT. Arms were kept up during the whole procedure. A five-second syngo DynaCT Cardiac run was performed without contrast (Video 6). During this rotational acquisition a pigtail catheter was positioned in the aortic root to visualize the position of the aorta and the aortic root as landmarks for the syngo InSpace 3-D/3-D registration. Patient was asked just to hold his breath, i.e., no deep inspiration or expiration in order to be in a similar breathing situation as during the remaining procedure. This helps increasing the overlay accuracy.?? 3-D/3-D registration of syngo DynaCT Cardiac image and CT was performed in syngo InSpace with the pigtail catheter and the mitral valve serving as landmarks. (Video 7).??

The overlaid 3-D markers helped as additional guidance during the procedure for:
    •    a) the puncture of the atrial septum
    •    b) the progression of a guidewire through a leak (Video 8)
    •    c) the adjustment of the closure devices (Video 9)

 

Related Content

News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
News | Heart Valve Technology

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
Subscribe Now